# ONO-4538 Phase I Study in Patients With Solid Tumor

> **NCT02261285** · PHASE1 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Advanced Solid Tumors
- Recurrent Solid Tumors

## Interventions

- **DRUG:** ONO-4538

## Key facts

- **NCT ID:** NCT02261285
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02261285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02261285, "ONO-4538 Phase I Study in Patients With Solid Tumor". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02261285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*